Corrado Advisors, LLC Vista Gen Therapeutics, Inc. Transaction History

Corrado Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 11, 2018	SELL	$1.23 - $1.49 $55,876 - $67,687	-45,428 Closed	0 $0
Q2 2018 Jul 09, 2018	SELL	$0.85 - $1.5 $17,850 - $31,500	-21,000 Reduced 31.61%	45,428 $62,000
Q1 2018 Apr 06, 2018	BUY	$0.91 - $1.73 $60,449 - $114,920	66,428 New	66,428 $62,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $730M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Corrado Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Corrado Advisors, LLC with notifications on news.